IL6 and type 2 diabetes mellitus: In a clinical study of T2DM patients, increased expression of TLR4, MyD88, phosphorylated I-κB, TNF-α, and IL-6, but decreased levels of caveolin-1 and total I-κB in monocytes were observed.